ENDRA Life Sciences

NDRA · NASDAQ

$4.47−$0.28 (−5.89%)TodayMarket closed ·
Prev close $4.75

Who owns NDRA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 21.2% of NDRA’s shares.

  • ATW Partners LLC5.4%
  • DiGiandomenico (Anthony)3.6%
  • Lipman (John Carter)3.6%
  • Altium Capital Management LP2.8%
  • Next 6 largest institutions5.8%
  • All other shareholders78.8%
Top institutional holders of NDRA
HolderShares% of shares
ATW Partners LLC116.02K5.45%
DiGiandomenico (Anthony)76.27K3.58%
Lipman (John Carter)76.10K3.57%
Altium Capital Management LP59.27K2.78%
Jacroux (Richard)33.46K1.57%
Citadel Advisors LLC29.92K1.40%
Citizens Financial Group, Inc.28.40K1.33%
Geode Capital Management, L.L.C.14.91K0.70%
Vanguard Fiduciary Trust Co10.12K0.48%
Vanguard Capital Management, LLC7.34K0.34%

Largest mutual fund holders

Top mutual fund holders of NDRA
HolderShares% of shares
Vanguard Extended Market Index Fund7.34K0.34%
Fidelity Extended Market Index Fund6.58K0.31%
Fidelity NASDAQ Composite Index Fund2.98K0.14%
Fidelity Series Total Market Index Fund1.60K0.07%

Short interest

Settled Sep 30, 2026

Shares short
28.23K
Days to cover
1.00
% of shares outstanding
1.33%
Average daily volume
49.31K
Change since last report
−9.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.